Gene expression studies indicate that hypermutated biliary tract cancer tumors frequently exhibit increased checkpoint molecule expression, such as CTLA-4, PD-L1, and LAG3, actively suppressing the immune response (64, 65). Here, CTLA4 is linked to biliary tract neoplasm.